Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases – the multicenter randomized controlled PUMP trial

[1]  M. Gönen,et al.  Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  William R Jarnagin,et al.  Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? , 2015, Annals of surgery.

[3]  C. Verhoef,et al.  The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  W. Jarnagin,et al.  Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes. , 2015, Annals of surgery.

[5]  M. Koch,et al.  Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy , 2014, BMC Cancer.

[6]  R. Parks,et al.  Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. , 2013, The Lancet. Oncology.

[7]  M. Gonen,et al.  Conversion to Complete Resection and/or Ablation Using Hepatic Artery Infusional Chemotherapy in Patients with Unresectable Liver Metastases from Colorectal Cancer: A Decade of Experience at a Single Institution , 2013, Annals of Surgical Oncology.

[8]  Z. Hamady,et al.  Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases , 2013, The British journal of surgery.

[9]  R. Parks,et al.  Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983) , 2012, Annals of surgery.

[10]  M. D'Angelica,et al.  Role of intra‐arterial hepatic chemotherapy in the treatment of colorectal cancer metastases , 2010, Journal of surgical oncology.

[11]  N. Kemeny,et al.  Regional hepatic chemotherapies in treatment of colorectal cancer metastases to the liver. , 2010, Seminars in oncology.

[12]  L. Schwartz,et al.  Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  L. Schwartz,et al.  Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  N. Kemeny,et al.  Regional chemotherapy: a focus on hepatic artery infusion for colorectal cancer liver metastases. , 2008, Surgical oncology clinics of North America.

[15]  Thomas Gruenberger,et al.  Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial , 2008, The Lancet.

[16]  Yuman Fong,et al.  Actual 10-year survival after resection of colorectal liver metastases defines cure. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  N. Kemeny,et al.  Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  L. Ben-Porat,et al.  Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. , 2005, Journal of the American College of Surgeons.

[19]  M. Gonen,et al.  Hepatic arterial infusion after liver resection. , 2005, The New England journal of medicine.

[20]  S. Lipsitz,et al.  Abstracts reprinted from Journal of Clinical Oncology , 2002, Annals of Surgical Oncology.

[21]  L H Blumgart,et al.  Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. , 1999, The New England journal of medicine.

[22]  L H Blumgart,et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.

[23]  W. Bechstein,et al.  Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen) , 1998, Annals of surgery.

[24]  F. Lévi,et al.  Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. , 1996, Annals of surgery.

[25]  J. Doroshow,et al.  Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries , 1986, Cancer.

[26]  Ensminger Wd,et al.  Clinical pharmacology of hepatic arterial chemotherapy. , 1983 .

[27]  W. Ensminger,et al.  Clinical pharmacology of hepatic arterial chemotherapy. , 1983, Seminars in oncology.

[28]  N. Ackerman.  The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. , 1974, Surgery.

[29]  C. Breedis,et al.  The blood supply of neoplasms in the liver. , 1954, The American journal of pathology.